Drug Type Small molecule drug |
Synonyms Compound C19(China Pharmaceutical University) |
Target |
Action inhibitors |
Mechanism MTDH inhibitors(metadherin inhibitors), SND1 inhibitors(staphylococcal nuclease and tudor domain containing 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H12FN3O2S |
InChIKeyQVGOZTAKUTYVGA-UHFFFAOYSA-N |
CAS Registry3052204-80-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | United States | 10 Jan 2025 |